Welcome
Support Centre
21 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Identification of cardiac dysfunction in a GP outpatient setting using handheld echocardiography and brain natriuretic peptide (BNP) point of care testing
ISRCTN ISRCTN21944979
ClinicalTrials.gov identifier
Public title Identification of cardiac dysfunction in a GP outpatient setting using handheld echocardiography and brain natriuretic peptide (BNP) point of care testing
Scientific title Diagnostic utility of point-of-care B-type-natriuretic peptide and handheld echocardiography in the primary care assessment of patients with suspected heart failure – the “Handheld-BNP”- Study, a four-arm randomised controlled trial
Acronym Handheld-BNP-Study
Serial number at source N/A
Study hypothesis Use of handheld echocardiography and/or BNP point of care testing improves the rate of correct heart failure diagnoses in a GP outpatient setting.

Please note that the scientific title was added to this trial record as of 24/08/2009.
Lay summary
Ethics approval Approved by the Ethics Committee of the University of Würzburg and the State Ethics Committees of Bavaria and North Rhine Westfalia in 2004.
Study design Four-arm diagnostic randomised controlled trial
Countries of recruitment Germany
Disease/condition/study domain Heart failure diagnosis
Participants - inclusion criteria 1. Age >18 years
2. Written informed consent
3. A diagnosis of heart failure suspected by the GP solely on the grounds of history taking
Participants - exclusion criteria Diagnosis of heart failure confirmed or excluded earlier.
Anticipated start date 01/03/2004
Anticipated end date 31/12/2006
Status of trial Completed
Patient information material
Target number of participants 960
Interventions This is a 4-arm diagnostic randomised study. GPs are trained and certified by experts to handle the diagnostic tools; each GP diagnoses a predefined number of patients with suspected heart failure using:
1. No additional tools
2. Handheld echocardiography
3. BNP point of care test
4. Handheld echocardiography and BNP test

GPs are randomly allocated 1:1:1:1 to the four diagnostic modalities. Within 14 days the diagnosis of the GP is verified or falsified by a cardiologist.
Primary outcome measure(s) Concordance/discordance of diagnosis between GP and cardiologist.
Secondary outcome measure(s) 1. Agreement between BNP point of care test and BNP reference test at core lab
2. Time needed to train and certify GPs in the different diagnostic tools
Sources of funding 1. German Federal Ministry of Education and Research (Bundesministerium Für Bildung und Forschung [BMBF]) (Germany)
2. Philips Medizinsysteme Ultraschall (Germany)
3. Biosite Diagnostics GmbH (Germany)
Trial website
Publications
Contact name Prof  Christiane E  Angermann
  Address Klinikstrasse 6-8
  City/town Wuerzburg
  Zip/Postcode 97070
  Country Germany
  Tel +49 (0)931 201 70460
  Fax +49 (0)931 201 71240
  Email angermann_c@klinik.uni-wuerzburg.de
Sponsor University of Wuerzburg (Germany)
  Address Sanderring 2
  City/town Wuerzburg
  Zip/Postcode 97070
  Country Germany
  Tel +49 (0)931 31 2231
  Fax +49 (0)931 31 2100
  Email kanzler@zv.uni-wuerzburg.de
Date applied 21/09/2005
Last edited 24/08/2009
Date ISRCTN assigned 30/11/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central